Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood

Affiliations

• ¹ Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University, No. 100 Haining Road, 200080, Shanghai, China.
• ² Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
• ³ Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
• ⁴ Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University, No. 100 Haining Road, 200080, Shanghai, China. lipingwan@sjtu.edu.cn.
• ⁵ Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University, No. 100 Haining Road, 200080, Shanghai, China. shongxm@sjtu.edu.cn.